Clinical Efficacy and Safety of Using 3.0mg Liraglutide to Treat Weight Regain After Roux-en-Y Gastric Bypass Surgery
Clinical trial NCT03048578 · COMPLETED
Trial details
- NCT number
- NCT03048578
- Sponsor
- NYU Langone Health
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-22
- Primary completion
- 2021-03-02
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.